By Christy Santhosh and Mrinalika Roy April 30 (Reuters) - Eli Lilly hiked its full-year profit and revenue forecasts on Thursday, as surging demand for its GLP-1 weight-loss and diabetes drugs helped offset lower prices across U.

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader whose husband found a solution for seborrheic dermatitis on his scalp.

Researchers Found a Hidden Downside to Popular Weight Loss Drugs Despite the Fat Loss Benefits

Boehringer Ingelheim’s glucagon/GLP-1 dual agonist has driven 16.6% weight loss at Week 76 of a phase 3 study. While the result fell short of the bar set by existing drugs, the

Weight loss drugs are changing how the wedding dress industry approaches finding the perfect fit. According to a Wall Street Journal report, businesses are struggling to keep up with fluctuating dress